Formula Image (Image 1)
Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 0591-4385
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 0591-4385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Image 2)
Fosaprepitant is a sterile lyophilized powder for intravenous use in single-dose vial packaging containing 150mg/vial. It is used to treat chemotherapy-induced nausea and vomiting. It should be stored in room temperature and reconstituted with sterile water or other compatible solutions. The entire contents should be withdrawn from the vial and diluted before use. Unused portions should be discarded and the single-dose vial packaging has serialization coding area to track its usage. The given text also contains product code and identification number.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
